Latest News

Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congre...

Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congress 20

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatme...

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment fo

Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be ...

Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be prese

Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazi...

Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) T

Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion A...

Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across

Teva Reports Second Quarter 2021 Financial Results

Teva Reports Second Quarter 2021 Financial Results

Teva Announces Changes to Executive Management Team

Teva Announces Changes to Executive Management Team

Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 2...

Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 20

Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due...

Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Ja...

Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan f

Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution...

Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live w...

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with R

Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Facto...

Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors Ma

New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European ...

New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Acade